Safety and efficacy of L-Glutamine in reducing the frequency of acute complications among patients with sickle cell disease: A randomized controlled study
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-05877-8 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Annals of Hematology, 2024. Verfasst von Fatma Soliman Elsayed Ebeid und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hematology Oncology and BMT Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt. dr.fatma_ebeid@yahoo.com. Hauptthemen laut MEDLINE: Glutamine, Anemia, Sickle Cell. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ain Shams University.
Abstract (Originalsprache)
To evaluate the safety and efficacy of L-glutamine in reducing vaso-occlusive crisis (VOC) and improving cerebral arterial blood flow in children with sickle cell disease (SCD). This is an interventional randomized controlled trial that recruited sixty SCD patients, aged 9.2 ± 3.7 years, who had at least two VOCs during the last 12 months and on a stable dose of hydroxyurea. They were randomly assigned in a 1:1 ratio to receive glutamine (0.3 gm/kg/dose/12h) orally for 24 weeks or the standard of care (SOC). All patients had VOCs in the last year > 3, those on glutamine had a higher number of VOCs and hospitalization for VOC in the last year. There was a decreasing trend in the number, severity, and hospitalization of VOC and a significantly lower cumulative number of VOCs and hospitalizations in the glutamine group than in SOC (p = 0.008, p < 0.001 respectively). Time-averaged mean maximum velocity for the glutamine group had a marginal increase in both middle cerebral arteries, all values remained normal within a normal range, and in both internal carotid arteries, values increased from abnormally low to normal ranges at week 24. Glutamine reduced the number of VOCs and severity and may have a potentially favorable impact on the cerebral arterial flow velocities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Hematology Oncology and BMT Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt. dr.fatma_ebeid@yahoo.com.
- Faculty of Medicine, Ain Shams University Research Institute-Clinical Research Center (MASRI-CRC), Cairo, Egypt. dr.fatma_ebeid@yahoo.com.
- Pediatric Hematology Oncology and BMT Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
- Misr's Children Hospital, Health Insurance Organization, Cairo, Egypt.
- Radio-diagnosis Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
- Pediatric Department, Egyptian Atomic Energy Authority, National Centre for Radiation Research and Technology, Cairo, Egypt.
Förderung
- Ain Shams University
Zitieren
APA
Ebeid, F. S. E., Aly, N. H., Shaheen, N. M., Abdellatif, S. M. A., Okba, A. A. M., Gad, N. A., & Makkeyah, S. M. (2024). Safety and efficacy of L-Glutamine in reducing the frequency of acute complications among patients with sickle cell disease: A randomized controlled study. Annals of Hematology. https://doi.org/10.1007/s00277-024-05877-8
Vancouver
Ebeid FSE, Aly NH, Shaheen NM, Abdellatif SMA, Okba AAM, Gad NA, et al. Safety and efficacy of L-Glutamine in reducing the frequency of acute complications among patients with sickle cell disease: A randomized controlled study. Annals of Hematology. 2024. doi:10.1007/s00277-024-05877-8
BibTeX
@article{Ebeid2024,
author = {Ebeid, Fatma Soliman Elsayed and Aly, Nihal Hussien and Shaheen, Naglaa Mohammed and Abdellatif, Samah Mohammed Ahmed and Okba, Ahmed Ashraf Mahmoud and Gad, Nada Ayman and Makkeyah, Sara Mostafa},
title = {Safety and efficacy of L-Glutamine in reducing the frequency of acute complications among patients with sickle cell disease: A randomized controlled study},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-05877-8}
}
EUVIMED